JPRN-UMIN000030316已完成未知
investigator initiated study of long-term treatment of Rhododenol-induced Leukoderma with Bimaprost - investigator initiated study of long-term treatment of Rhododenol-induced Leukoderma with Bimaprost
Teikyo University School of Medicine0 个研究点目标入组 10 人开始时间: 2017年12月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Age under twenty years old at the time of inforomed consent. 2) Those who were suspected of concomitant vitiligo vulgaris. 3) Those who show skin problems such as erythema at the site of target region. 4) Those subjects who were considered by the principal investigator or sub-investigator to be showing skin problem which might be related to previous study. 5) Those subjects who were considered by the principal investigator or sub-investigator to be difficult to comply with compliance. 6) Those who show allagic reaction against Bimatoprost. 7) Those women who are pregnant or possibly pregnant or during lactation or those who cannot agree with contraception during the study. 8) Those otherwise principal physician considered unsuitable to include in this study.
研究者
相似试验
进行中（未招募）
不适用
Prospective controlled long-term study to investigate cognitive impairment in patients with previous treatment to intensive care units (ICU), with and without SARS-CoV-2-infection and in mild COVID-19 patients without previous ICU treatmentCOVID-19G62G72U07.1Other polyneuropathiesOther myopathiesCOVID-19, virus identifiedDRKS00025523eurologische Fachkliniken Beelitz64
已完成
2 期
Clinical trial to investigate the effect of long-term intake of tomato juice on atherosclelosisMetabolic symdromeJPRN-UMIN000001173Tokushima University Hospital40
进行中（未招募）
不适用
Estudio abierto de tratamiento a largo plazo para evaluar la seguridad, la tolerabilidad y la eficacia a largo plazo de neramexano en pacientes con acúfenos subjetivosAn Open-Label, Long-Term Treatment Study to assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective TinnitusAcúfenos subjetivosLong-term safety, tolerability and efficacy of Neramexane in Patients with subjective Tinnitus.MedDRA version: 9.1Level: LLTClassification code 10042398Term: Subjective tinnitusEUCTR2008-001432-13-ESMerz Pharmaceuticals GmbH840
进行中（未招募）
不适用
Clinical Study to Investigate the Long-Term Efficacy, Safety, and Immunogenicity of human-cl rhFVIII in Previously Treated Patients with Severe Haemophilia A – Extension Study to GENA-01Severe haemophilia A (FVIII:C <1%)MedDRA version: 12.1Level: LLTClassification code 10018937Term: Haemophilia AEUCTR2010-023242-69-DEOctapharma AG25
进行中（未招募）
不适用
An Open-Label, Long-Term Treatment Study to assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitusong-term safety, tolerability and efficacy of Neramexane in Patients with subjective Tinnitus.MedDRA version: 9.1Level: LLTClassification code 10042398Term: Subjective tinnitusEUCTR2008-001432-13-NLMerz Pharmaceuticals GmbH840